138 related articles for article (PubMed ID: 2015407)
1. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies.
Rabinowe SN; Soiffer RJ; Tarbell NJ; Neuberg D; Freedman AS; Seifter J; Blake KW; Gribben JG; Anderson KC; Takvorian T
Blood; 1991 Apr; 77(8):1837-44. PubMed ID: 2015407
[TBL] [Abstract][Full Text] [Related]
2. [Hemolytic uremic syndrome after bone marrow transplantation].
Arai A; Sakamaki H; Tanikawa S; Akiyama H; Onozawa Y; Okamoto R; Maeda Y; Sasaki T; Kaku H; Tsuzuki S; Takamoto S
Rinsho Ketsueki; 1998 Jun; 39(6):422-6. PubMed ID: 9695669
[TBL] [Abstract][Full Text] [Related]
3. Microangiopathic hemolytic anemia and renal impairment following autologous bone marrow transplantation: a case of hemolytic uremic syndrome?
Wassmann B; Martin H; Elsner S; Bruecher J; Thaiss F; Stahl RA; Hoelzer D
Bone Marrow Transplant; 1994 Nov; 14(5):849-51. PubMed ID: 7889019
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation.
Silva VA; Frei-Lahr D; Brown RA; Herzig GP
J Clin Apher; 1991; 6(1):16-20. PubMed ID: 2045377
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic uremic syndrome following bone marrow transplantation.
Juckett M; Perry EH; Daniels BS; Weisdorf DJ
Bone Marrow Transplant; 1991 May; 7(5):405-9. PubMed ID: 2070153
[TBL] [Abstract][Full Text] [Related]
6. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
7. [An autopsy case report of hemolytic uremic syndrome after allogeneic bone marrow transplantation].
Ohomoto A; Kohno M; Matsuyama R
Rinsho Ketsueki; 1993 Feb; 34(2):229-31. PubMed ID: 8492423
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation.
Oursler DP; Holley KE; Wagoner RD
Am J Nephrol; 1993; 13(2):167-70. PubMed ID: 8393614
[TBL] [Abstract][Full Text] [Related]
9. Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation.
Srivastava A; Gottlieb D; Bradstock KF
Bone Marrow Transplant; 1995 Jun; 15(6):863-7. PubMed ID: 7581082
[TBL] [Abstract][Full Text] [Related]
10. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation.
Antignac C; Gubler MC; Leverger G; Broyer M; Habib R
Kidney Int; 1989 Jun; 35(6):1336-44. PubMed ID: 2671466
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome after autologous BMT without TBI.
Raybon KB; Snyder MJ; Halvorson RD
Bone Marrow Transplant; 1996 May; 17(5):897-8. PubMed ID: 8733719
[No Abstract] [Full Text] [Related]
12. Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.
Hale GA; Bowman LC; Rochester RJ; Benaim E; Heslop HE; Krance RA; Horwitz EM; Cunningham JM; Tong X; Srivastava DK; Handgretinger R; Jones DP
Biol Blood Marrow Transplant; 2005 Nov; 11(11):912-20. PubMed ID: 16275594
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
[TBL] [Abstract][Full Text] [Related]
14. Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr Shariati Hospital in Tehran.
Saddadi F; Najafi I; Hakemi MS; Falaknazi K; Attari F; Bahar B
Iran J Kidney Dis; 2010 Jan; 4(1):20-6. PubMed ID: 20081300
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.
Verdonck LF; Dekker AW; Lokhorst HM; Petersen EJ; Nieuwenhuis HK
Blood; 1997 Nov; 90(10):4201-5. PubMed ID: 9354692
[TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
17. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.
Carlson K; Smedmyr B; Hagberg H; Oberg G; Simonsson B
Bone Marrow Transplant; 1993 Mar; 11(3):205-8. PubMed ID: 8467284
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
Yee GC; McGuire TR
Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
[TBL] [Abstract][Full Text] [Related]
19. Renal involvement in bone marrow transplantation.
Otani M; Shimojo H; Shiozawa S; Shigematsu H
Nephrology (Carlton); 2005 Oct; 10(5):530-6. PubMed ID: 16221108
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation.
Verdonck LF; de Gast GC; van Heugten HG; Nieuwenhuis HK; Dekker AW
Blood; 1991 Aug; 78(3):844-8. PubMed ID: 1650265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
